Dexcom (DXCM): Officer filed to sell ~$202K
SADIE STERN, Officer at Dexcom, filed to sell ~$202K of Dexcom shares.
- ~$202K
- planned to sell · 2,565 shares, around Oct 27, 2026
- Planned for
- Oct 27, 2026
- Notice filed
- Oct 27, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 27, 2026InsiderOfficer sold ~$227K of DXCM shares in the open market
- Sep 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 10, 2026, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom” or the “Company”), pursuant to the Amended and Restated Bylaws of the Company, increased the size of the Board to thirteen directors and appointed Glenn S. Boehnlein as a director, effective immediately.”
- Sep 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 10, 2026, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom” or the “Company”) appointed Jereme Sylvain, the Company’s EVP, Chief Financial Officer, to the role of EVP, Chief Operating Officer and Chief Financial Officer, effective September 14, 2026.”
- Sep 10, 2026InsiderOfficer sold ~$303K of DXCM shares in the open market
- Sep 14, 2026InsiderDirector sold ~$130K of DXCM shares in the open market
- Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$692K)
- Sep 28, 2026InsiderOfficer sold ~$221K of DXCM shares in the open market
- Oct 15, 2026InsiderOfficer sold ~$145K of DXCM shares in the open market
- Oct 27, 2026InsiderOfficer sold ~$202K of DXCM shares in the open market
What came next
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Dexcom
For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DXCM page.
How this filing works
Explore the data
Common questions
Which Dexcom (DXCM) insider traded, and how much?
SADIE STERN, Officer at Dexcom, filed to sell ~$202K of Dexcom shares. 2,565 shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Oct 27, 2026. Notice filed: Oct 27, 2026.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Dexcom recently?
For Dexcom, OQRO holds 20 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the DXCM page.
Does this mean DXCM stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Dexcom
- SEC Form 4Nov 18, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Oct 28, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 144Oct 15, 2026
Everything OQRO holds on this company is on its DXCM page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
